Turn Therapeutics Inc. TTRX
9.92 USD +0.13 (+1.33%)
At closeNov 10, 2026, 4:00 PM EST
9.92 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
9.52 Day range 10.22
2.57 52-week range 16.45
- YTD
- +151.78%
- 1 year
- +140.19%
- Market cap
- 301.25M
- EPS (ttm)
- -0.29
- YTD return
- +151.78%
- 1-year return
- +140.19%
- Volume
- 88.09K
- Avg volume
- 112.66K
- Open
- 9.72
- Previous close
- 9.79
- Day's range
- 9.52 – 10.22
- 52-week range
- 2.57 – 16.45
5D -0.72 (-7.06%)
Financials — quick view
TTRX Revenue — quarterly 0
TTRX Net income — quarterly -5.85M
TTRX EPS — quarterly -0.20
News
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results 
Turn Therapeutics Q3 EPS $(0.21) Misses $(0.09) Estimate 
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results 
Turn Therapeutics' GX-03 Earns “Developmental Immunology Solution of the Year” in 2026 BioTech Breakthrough Awards Program 
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday 
This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday 
WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10 
U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat 
This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24
Your note
Sign in to keep a note on TTRX — it syncs with the Stock Master app.